| (210) | Number of the EPO application | 16704511 |
| (220) | Filing date of the EPO application | 2016.01.20 |
| (80) | EPO patent specification publication (B) | EPB nr. 10/2022, 2022.03.09 |
| (110) | EPO patent number | 3247393 |
| (21) | Number of the application | e 2017 0292 |
| (71) | Name(s) of applicant(s), code of the country | Cytomx Therapeutics Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | MOORE Stephen James, US;
NGUYEN Margaret Thy Luu, US;
HOSTETTER Daniel R., US;
VASILJEVA Olga, US;
SAGERT Jason Gary, US;
TERRETT Jonathan Alexander, US;
WEST James William, US; |
| (73) | Name(s) of owner(s), code of the country | Cytomx Therapeutics Inc., US; |
| (54) | Title of the invention | MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/05 (2006.01.01); A61K 39/00 (2006.01.01); A61P 35/00 (2006.01.01); C07K 16/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.02.28 |
| (30) | Priority | 201562105490 P, 2015.01.20, US; 201562258015 P, 2015.11.20, US; 201662278713 P, 2016.01.14, US |
| (86) | International application | PCT/US2016/014132, 2016.01.20 |
| (87) | International publication | WO 2016/118629, 2016.07.28 |